Published on March 20, 2010 at 12:55 AM
China Sky One
Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a
leading fully integrated pharmaceutical company producing over-the-counter
drugs in the People's Republic of China ("PRC"), today announced the receipt
of Conformite Europeenne (CE) certification for its Myocardial Infarction and
Urine Microalbumin Diagnostic Kits. The CE marking certifies that the two
products have met the European Union (EU) health and safety standards and are
approved for sale in the 27 EU countries and four members of the European Free
Trade Association (EFTA).
The Company also received ISO 9001 and ISO 13485 certifications for its
Myocardial Infarction, Urine Microalbumin and Early Pregnancy Diagnostic Kits.
ISO certifications set stringent, globally recognized management system
standard that enhances its product marketing. The two ISO certifications are
valid through October 2014.
Investors can visit the Company's website http://www.cski.com.cn , under
the section of News, to view all these certifications.
"We are honored to receive the CE marking and the ISO certifications,
which reinforce the high quality of our products and manufacturing standards
and pave way for exporting the diagnostic kits in the EU and other markets,"
said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "According
to agreements with our distributors in Indonesia, Turkey, Singapore and
Vietnam, we will enter into definitive contracts with the distributors
following receipt of the CE marking. The CE marking and ISO certifications
also strengthen the Company's ability to advance our negotiations with
potential distributors from many other countries. We look forward to launching
our diagnostic kits in promising international markets beginning in 2010."
SOURCE China Sky One Medical, Inc.